Relmada Therapeutics Price Target Cut to $2.00/Share From $3.00 by Goldman Sachs
Relmada Therapeutics Price Target Cut to $2.00/Share From $3.00 by Goldman Sachs
高盛将Relmada Therapeutics 的目标股价从每股3.00美元降至每股2.00美元。
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册